Support and Resistance Levels
Past performance
About FDC Ltd FDC Limited is a research-driven pharmaceutical company involved in the production and distribution of Formulations and Active Pharmaceutical Ingredients (APIs). Established as Fairdeal Corporation in 1936, FDC has evolved into a significant player in both regulated and emerging markets, including the US and Europe. The company has a notable presence in various therapeutic segments, leading in oral rehydration salts with its flagship product, Electral. FDC operates through seven marketing divisions, covering 14 therapeutic segments, and has a diversified portfolio including pharmaceuticals, nutraceuticals, and food products.
FDC has expanded its global footprint with wholly owned subsidiaries in the USA and UK, and a joint venture in South Africa. It has invested in modern manufacturing facilities across India, meeting international standards, and has received various certifications, including US FDA and EU GMP. The company actively pursues strategic growth through product launches, acquisitions, and infrastructure development. Recent efforts include launching new products, enhancing its nutraceuticals segment, and expanding its API registrations globally. FDC continues to innovate and adapt, focusing on maintaining regulatory compliance and increasing its global market share.